CHÉOS to collaborate with global genomics organization
CHÉOS is collaborating with the world’s largest genomics organization, Beijing Genomics International (BGI), to research the health economics of personalized medicine.
The collaboration with BGI is part of a larger global partnership to bring together advanced technologies and individualized therapy for cancer and other diseases. Five health and research organizations, including Providence Health Care, will work together on applying next generation sequencing technologies and big data to accelerate personalized medicine and improve outcomes for patients.
The partnership was recognized on October 19, when a Memorandum of Understanding (MOU) was signed by the parties at a ceremony at the Vancouver Board of Trade.
Read more on our website.
[Photo from the MOU signing. Jay Shaw Photo | St. Paul’s Foundation]
New research series: The Evidence Speaks
We’re proud to introduce our new series, The Evidence Speaks, a recurring feature highlighting the latest in CHÉOS research. This series will feature summaries of select publications as well as in-depth features on the latest work from our investigators.
Working together to improve patient engagement
On September 28, over 40 health leaders, researchers, faculty members, and people with lived experience gathered for a one-day symposium to discuss initiatives and best practices for patient engagement in health research.
Attendees heard about initiatives and projects from across British Columbia where patients have influential roles in health research decision-making.
Read more and view some images from the event on our website.
Dr. Mark Harrison appointed to Arthritis Research Canada
Arthritis Research Canada has appointed CHÉOS Scientist Dr. Mark Harrison as an Affiliate Scientist. In addition to his CHÉOS appointment, Dr. Harrison is also an Assistant Professor in the Faculty of Pharmaceutical Sciences at UBC. Congrats, Mark!
Kidney transplant and dialysis forum
On October 18, St. Paul’s nephrologists held a public forum on kidney transplant and dialysis.
CHÉOS Scientists Drs. Adeera Levin (pictured) and Monica Beaulieu, along with their colleague Dr. David Landsberg, discussed kidney care, the transplant patient and donor experience, and what the future holds for patients living with kidney disease.
[Image courtesy of the St. Paul’s Foundation]
SMDM 2016
The Society for Medical Decision-Making (SMDM) 2016 Annual North American Meeting is underway in Vancouver. CHÉOS Scientist Dr. Nick Bansback is co-chairing the conference. Follow along on Twitter at @socmdm and with the hashtag #SMDM16.
World Thrombosis Day 2016
October 13 was World Thrombosis Day. Thrombosis is the formation of blood clots in arteries (arterial thrombosis) or veins (venous thrombosis) which can have potentially fatal consequences. Read about the work our scientists are conducting in this field of research.
CHÉOS in the media
“New curriculum raises kidney awareness.” EurekAlert! Dr. Adeera Levin. October 6, 2016.
“First Maple Ridge talk drills down on why people end up on the street.” Maple Ridge and Pitt Meadows News. Dr. Michael Krausz. October 21, 2016.
Award and scholarship opportunities
MSFHR Scholar Awards. LOI deadline October 31.
MSFHR Health Policy Fellowship. Deadline November 4.
Harkness Fellowships in Health Care Policy and Practice. Deadline November 14.
SPOR Patient-Oriented Research Collaboration Grants. Deadline December 13.
Staff announcements
Please join us in welcoming Leslie Love, who started work this month as Senior Project Manager for CHÉOS and the CIHR Canadian HIV Trials Network. Ms. Love has extensive experience in project management and facilitation in health research. Most recently, she worked with the Rick Hansen Institute; her previous roles include the UBC Division of Respiratory Medicine (Pacific Lung Research Centre), as well as UBC’s B.C. Centre for Disease Control (Epidemiology Services).
